RXi Pharmaceuticals Corp. (RXII) Cuts Q2 Loss to 4c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts RXII Hot Sheet
Join SI Premium – FREE
RXi Pharmaceuticals Corp. (Nasdaq: RXII) reported Q2 loss of ($0.04), versus a loss of ($0.12) reported in the same period last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Progress Software Corporation (PRGS) Tops Q3 EPS by 17c ; Offers Guidance
- IDT Corp. (IDT) Misses Q4 EPS by 3c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
